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ABSTRACT: Cancer cells generally possess higher levels of reactive
oxygen species than normal cells, and this can serve as a possible
therapeutic target. In this proof-of-concept study, an antioxidant-inspired
drug discovery strategy was evaluated using a hydroxycinnamic acid
derivative. The processing of oxidized mixtures of p-coumaric acid
methyl ester (pcm) revealed a new antitumor lead, graviquinone.
Graviquinone bypassed ABCB1-mediated resistance, induced DNA
damage in lung carcinoma cells but exerted DNA protective activity in
normal keratinocytes, and modulated DNA damage response in MCF-7 cells. The cytotoxic eﬀect of pcm in MCF-7 cells was
potentiated under H2O2-induced oxidative stress, and the formation of graviquinone was conﬁrmed by Fenton’s reaction on
pcm. In silico density functional theory calculations suggested graviquinone as a kinetic product of pcm-scavenging •OH
radicals. Our results demonstrate the pharmacological value of an in situ-formed, oxidative stress-related metabolite of an
antioxidant. This might be of particular importance for designing new strategies for antioxidant-based drug discovery.
■ INTRODUCTION
Hydroxycinnamic acids, such as p-coumaric, caﬀeic, ferulic, and
chlorogenic acids, are among the most abundant dietary
antioxidants. They occur in many vegetables (e.g., olive, potato,
lettuce, broccoli, cauliﬂower, chicory, and cabbage), fruits (e.g.,
various berries, grapes, dates, and apple), cereals (e.g., common
and hard wheat and cereal products such as bread), spices (e.g.,
clove, Ceylon cinnamon, nutmeg, and cumin), nuts (e.g.,
peanut), dark chocolate, vegetable oils, and beverages (e.g.,
beers, wines, fruit juices, tea, and coﬀee).1 The antioxidant
properties of these phenolic acids have been widely
described.2−4 They have been reported for a large variety of
bioactivities, including chemopreventive and antitumor eﬀects.
For example, caﬀeic acid methyl ester (cm) was shown to inhibit
colon carcinogenesis through the inhibition of tyrosine protein
kinase and arachidonic acid metabolism.5 Another example is
the chemopreventive activity of p-coumaric acid methyl ester
(pcm; also referred to as methyl-p-coumarate), which is enabled
by the induction of phase II metabolic enzymes such as quinone
reductase and glutathione-S-transferase.6
In addition to the antitumor and antioxidant potential of
hydroxycinnamic acids, some inspiring studies about their
oxidized metabolites have been published. Pieters et al. found
that Ag2O-catalyzed biomimetic oxidation of cm or ferulic acid
methyl ester (fm) in a mixture of anhydrous benzene and
anhydrous acetone yielded dihydrobenzofuran lignans with
highly potent in vitro antiproliferative activity on diﬀerent
cancer cell lines.7 The dimer of cm showed great antitumor
potential with growth inhibitory concentrations (GI50) lower
than 10 nM against breast cancer cell lines, MDA-MB-435,
MDA-N, and BT-549. Moreover, this compound was identiﬁed
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as a potent antitubulin agent.7 These dihydrobenzofuran lignans
were also reported to exert antiangiogenic activity,8 and another
study described similar activity of the fm-derived lignan on
angiogenesis.9 Recently, the above-mentioned dimer of cm
(referred to as Q2-3) attracted great attention for its
antimetastatic activity on mammary tumors because of the
interference with their microenvironment; namely, Q2-3 was
able to induce IL-25 secretion from tumor-associated
ﬁbroblasts.10
As one of the mechanisms preventing free-radical-associated
damage, antioxidants can scavenge free radicals. In turn, this
process may form oxidized metabolites with diﬀerent bio-
activities. The eﬀect of these metabolites on the overall
bioactivity may be minor, or at least diﬃcult to discriminate
with respect to that of their parental antioxidants within the cell
environment. However, these metabolites could be used as new
model compounds or leads in drug discovery. In this context,
and considering the intriguing antitumor potential of hydrox-
ycinnamic acids, this study aims at the investigation of both the
formation and the bioactivity of oxidized metabolites of pcm.
■ RESULTS AND DISCUSSION
Preparation of Oxidized Metabolites of pcm. As a ﬁrst
step, we aimed to study the eﬀect of various oxidative conditions
on the cytotoxic activity of pcm. The oxidation of pcm was
performed by a hypervalent iodine(III) reagent, phenyliodine
bis(triﬂuoroacetate) (PIFA), in acetonitrile (ACN), ACN−
water (9:1, v/v), methanol, or methanol−water (9:1, v/v), or
with pyridinium chlorochromate (PCC) in dichloromethane.
PIFA was selected based on two reasons. First, this reagent was
previously reported to react with p-phenols via a single-electron
transfer (SET) mechanism through a cation radical intermedi-
ate.11 Second, this cation radical intermediate can deprotonate
in aqueous medium and lead to the same phenoxyl radical that
would form in a hydrogen atom transfer (HAT) reaction. As p-
coumaric acid was previously suggested to scavenge reactive
oxygen species (ROS) either through SET or HAT mecha-
nism,12 we expected that PIFA-mediated oxidation of pcm
would lead to a metabolite pattern similar to that of ROS
scavenging. Following oxidation, each product mixture was
subjected to solid-phase extraction on silica to prevent false-
positive results because of residual traces of reagents. The
obtained product extracts (named OX1-5) were tested for their
cytotoxic activity in comparison with that of pcm on a mouse
lymphoma cell line (L5178) and its multidrug-resistant (MDR)
subcell line, obtained by transfection of L5178 with the human
ABCB1 gene (L5178B1). A dramatic increase in the cytotoxic
activity was observed with OX1 and OX2 as compared to that of
pcm (Figure 1A,B); hence, these conditions were chosen to
perform scale-up in order to allow the isolation of individual
active constituents. Altogether, three scale-up procedures were
performed, from which ﬁve metabolites (1−5, see Figure 1C)
were isolated by combined chromatographic techniques.
Structure elucidation of these compounds was (i) performed
by mass spectrometry (MS) and comprehensive one-dimen-
sional (1D) and two-dimensional (2D) nuclear magnetic
resonance (NMR) methods and then (ii) conﬁrmed by
comparing their chemical shifts with reported literature
values.13−16
Compound 1 has most likely been formed from pcm in a way
similar to that previously described for the dihydrobenzofuran
dimers of cm or fm, followed by the elimination of a phenol
moiety and the formation of benzofuran skeleton. The
formation of compounds 2 (i.e., cm) and 3 (p-hydroxy-
benzaldehyde) can intuitively be explained by the impact of
the oxidative environment. Compound 4 (methyl 2,5-
dihydroxycinnamate or methyl grevillate) represents a highly
unexpected structure, which has, however, previously been
isolated from natural sources.16 Considering the reaction
mechanism of phenol oxidation by PIFA,11 one can only
suspect the formation and opening-up of an epoxide
intermediate as an explanation for the unexpected migration
of the p-hydroxyl group to the meta-position. Compound 5
(known as graviquinone) is also a natural product that has ﬁrst
been isolated from the “silky oak,”Grevillea robustaA. Cunn, and
identiﬁed as a cytotoxic compound against MCF-7, NCI-H460,
and SF-268 cell lines in vitro.15 The p-quinol moiety of 5makes
it related to protoﬂavones that are known for their strong
antitumor activity in vitro and in vivo,17 as well as for their ability
Figure 1.Cytotoxic activity of pcm and its oxidizedmetabolite mixtures OX1-5 on L5178 (A) and L5178B1 (B) cancer cells, and chemical structures of
pcm and its oxidized metabolites isolated (C). Dilutions for each mixture were performed by calculating with the molecular mass of pcm; upward
arrows mark samples with IC50 values >150 μM. Reagents and solvents for obtaining each mixture were as follows. OX1: PIFA, ACN; OX2: PIFA,
ACN−water (9:1); OX3: PIFA, MeOH; OX4: PIFA, MeOH−water (9:1), and OX5: PCC, CH2Cl2.
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to bypass resistance mediated by the P-glycoprotein (P-gp)/
ABCB1 or breast cancer resistance protein/ABCG2 eﬄux
transporters.18
Antitumor Potential of Oxidized pcmMetabolites.The
in vitro cytotoxic activity of compounds 1−5 was tested on the
above-mentioned mouse lymphoma cell line pair (L5178 and
L5178B1). Following this, compounds 4 and 5 were also tested
on a diverse panel of cancer cell lines, including MCF-7, HeLa,
and SiHa, and several lung carcinoma cell lines, such as A549
adenocarcinoma, a highly metastatic large cell lung carcinoma
(NCI-H661), and a non-small-cell lung carcinoma (NCI-H460)
and its MDR counterpart (NCI-H460/R) developed by
continuous exposure of the initially sensitive cell line to
doxorubicin. Results of these bioassays are compiled in Table 1.
The parental antioxidant pcm exerted very low cytotoxic
activity as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assay, and the NCI-H460/R
cell line showed a nearly 10-fold cross-resistance to this
compound as compared to the NCI-H460 cells. Some of its
oxidized metabolites, however, exerted a great, ca. 2−3 orders of
magnitude stronger cytotoxic activity. Among the two identiﬁed
active metabolites (4 and 5), 2.4 times cross-resistance toward
the hydroquinone analogue compound 4 was observed in the
MDR cell line L5178B1, suggesting that this compound is likely a
substrate of the P-gp/ABCB1 eﬄux transporter. Nevertheless,
the resistance proﬁle of this compound was much more
favorable than that of pcm on the NCI-H460/NCI-H460/R
cell line, exhibiting a less than twice cross-resistance in the latter.
Compound 5 bypassed resistance of both the ABCB1-
transfected cell line and NCI-H460/R adapted to doxorubicin.
Its activity was as strong as that of the positive control
doxorubicin in L5178 cells, but while doxorubicin demonstrated
28.9 times higher IC50 in resistant L5178B1 compared to
corresponding sensitive L5178 cells, compound 5 was similarly
active in both cell lines. Moreover, compound 5 showed a nearly
10 times selective cytotoxicity against the lymphoma cell lines,
and a ca. 2−3 times selectivity against the NCI-460 and NCI-
661 cell lines versus the immortalized human keratinocytes
(HaCaT), suggesting a good selectivity proﬁle toward cancer
cells.
Cell death analysis by annexin-V/propidium iodide (PI)
staining revealed that both compounds 4 and 5 induce cellular
necrosis (Table 2).
Compound 4 exerted the strongest eﬀect on NCI-H460 cells,
which were also the most sensitive to 4 according to the
cytotoxicity assay. As the most prominent eﬀect, compound 5
increased the percentage of necrotic NCI-H661 cells from
2.58% (untreated control) to 44.82% (treated). This was similar
to our previous observations on a p-quinol ﬂavonoid,
protoapigenone, which also induced necrosis-type cell death
associated with ataxia telangiectasia and Rad3-related kinase
(ATR) inhibition through Chk1, leading to the accumulation of
DNA lesions.19 Considering the structural relationship between
protoapigenone and compound 5, our attention turned toward
its potential ability to exert DNA damage and interfere with
DNA damage response (DDR) at the same time.
As a marker of DNA damage, the expression of histone 2A.X
(H2A.X) was analyzed after treatment with compound 4 or 5.
The potential eﬀect of compound 5 on DDR was evaluated with
western immunoblotting after UV irradiation of MCF7 cells
(Figure 2).
The results clearly showed the induction of DNA damage by 5
in NCI-H460 and NCI-H460/R cells with signiﬁcantly T
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increased expression of H2A.X, which was, however, decreased
in normal HaCaT cells after treatment with 5. The results point
out the selectivity of compound 5 toward DNA damaging in
cancer cells. Compound 4 reduced the expression of H2A.X in
most of the cancer cells and also in HaCaT cells, indicating its
DNA protective activity (Figure 2A). ROS production was
Table 2. Cell Death Induction by Compounds 4 and 5 in Human Lung Carcinoma Cell Lines (NCI-H460, NCI-H460/R, A549,
and NCI-H661) and Normal Human Keratinocytes (HaCaT)a
cell line sample viable cells early apoptosis late apoptosis necrosis
NCI-H460 control 96.49 ± 0.96 0.45 ± 0.01 0.93 ± 0.04 2.13 ± 0.02
4 86.64 ± 1.73** 0.34 ± 0.01 5.10 ± 0.15** 9.92 ± 0.20**
5 89.13 ± 2.67* 0.21 ± 0.01 3.35 ± 0.07** 7.31 ± 0.22**
Dox 85.14 ± 3.07* 4.05 ± 0.12** 4.11 ± 0.23** 6.70 ± 0.24**
NCI-H460/R control 95.76 ± 2.87 0.22 ± 0.01 0.84 ± 0.01 3.17 ± 0.13
4 89.65 ± 1.79* 0.16 ± 0.01 2.48 ± 0.10* 7.71 ± 0.08**
5 90.03 ± 3.60* 0.12 ± 0.01 2.34 ± 0.07* 7.51 ± 0.15**
A549 control 96.45 ± 2.89 0.48 ± 0.01 1.54 ± 0.03 1.52 ± 0.05
4 88.24 ± 2.65* 2.36 ± 0.07* 5.62 ± 0.06** 3.78 ± 0.15*
5 92.78 ± 1.86 0.72 ± 0.03 3.93 ± 0.16* 2.57 ± 0.03*
NCI-H661 control 96.16 ± 0.96 0.31 ± 0.01 0.95 ± 0.03 2.58 ± 0.05
4 89.43 ± 1.79* 0.49 ± 0.02 3.39 ± 0.07* 6.69 ± 0.20*
5 45.43 ± 1.36*** 0.18 ± 0.01 9.57 ± 0.10*** 44.82 ± 1.79***
HaCaT control 95.63 ± 3.83 0.23 ± 0.01 2.26 ± 0.09 1.88 ± 0.02
4 90.95 ± 3.64* 0.50 ± 0.01 2.65 ± 0.08 5.90 ± 0.12**
5 91.50 ± 1.83 0.44 ± 0.01 2.85 ± 0.06 5.21 ± 0.16**
Dox 78.11 ± 2.38** 11.03 ± 0.14*** 3.04 ± 0.07 7.82 ± 0.12***
aDox: 40 nM of doxorubicin, used as positive control. Statistical evaluation was performed by two-way ANOVA followed by Dunnett’s multiple
comparisons test; *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Figure 2. DNA damaging eﬀect and ROS production by treatment with compound 4 or 5 and eﬀect of compound 5 on DDR. (A) DNA damaging
eﬀects of compounds 4 and 5 were examined by H2A.X relative expression. (B) ROS production was detected according to dihydroethidium (DHE)
ﬂuorescence. Both analyses were performed by ﬂow cytometry, and the results are given as the average ± standard deviation (SD) from three
independent experiments. Statistical evaluation was performed by two-way analysis of variance (ANOVA) followed by Dunnett’s multiple
comparisons test; ***: p < 0.001. CDDP: cisplatin. (C) Evaluation of the DNA damaging eﬀect of compound 5 and pcm by western immunoblotting;
MCF7 cells were pretreated with 10 μM of compound 5 or pcm for 30 min and exposed to UV irradiation (10 J/m2) in the following 1 h to induce
DDR. Protoapigenone (10 μM)was used as positive control. Results were analyzed by one-way ANOVA and data represent the mean± SD from three
independent experiments; *: p < 0.05, **: p < 0.01.
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assessed by DHE labeling that showed a signiﬁcant increase of
ROS levels in NCI-H460, A549, and NCI-H661 cells after
treatment with compound 5; however, it was decreased in NCI-
H460/R and HaCaT cells. These results also demonstrate the
selectivity of 5 toward cancer cells. The opposite eﬀect on NCI-
H460/R cells should be discussed in the light of our previously
published results regarding the lower antioxidant potential of
NCI-H460/R cells, as compared to that of their parental cell line
NCI-H460.20 Compound 4 decreased the level of ROS in all
tested cell lines including HaCaT cells (Figure 2B). The
obtained results indicate diﬀerent mechanisms of action for
compounds 4 and 5. Interestingly, the positive control cisplatin
(CDDP) signiﬁcantly increased ROS levels in normal HaCaT
cells without aﬀecting this measure in NCI-H460 cancer cells.
This also suggests that, at least in this regard, compound 5 has a
better selectivity proﬁle than the classical chemotherapeutic
drug cisplatin.
It is of interest that compound 5 acted as a potent modulator
of DDR through the inhibition of Chk1-S345 phosphorylation,
while pcm was completely inactive in this regard (Figure 2C).
The serine−threonine checkpoint kinases 1 and 2 (Chk1 and
Chk2, respectively) have key roles in the DNA damage signaling
response. Upon DNA damage, Chk1 is activated through
phosphorylation by ATR, and Chk2 is activated to a major
extent by ataxia telangiectasia mutated kinase (ATM). Chk1 is
especially important for the stability of stalled replication forks,
and DNA repair-defective tumor cells have been shown to
accumulate high levels of DNA damage.21 A growing body of
evidence suggests that small-molecule Chk1 inhibitors may act
as single agents against cancer cells with speciﬁc potential
genetic defects, as, for example, Fanconi anemia.22 In addition,
the sensitivity to Chk1 inhibition is also associated with
replication stress in many cancer cell types, such as neuro-
blastoma cell lines or metastatic melanoma, which were found to
have higher expression of Chk1 mRNA.23,24 Accordingly, our
results demonstrated that, as a Chk1 inhibitor, compound 5 has
a considerable potential to speciﬁcally target cancer cells with
high levels of endogenous DNA damage. Furthermore, the
increased expression of phosphorylated H2A.X is a well-known
marker of the DNA double-strand breaks (DSBs).25 We found
that, unlike normal HaCaT cells, cancer cells treated with
compound 5 showed a signiﬁcantly increased expression of
H2A.X (Figure 2A). As ATM-dependent phosphorylation is
also correlated with H2A.X phosphorylation, this suggests that
DSBs resulting from collapsed replication forks are responsible
for the ATM activation. In Figure 2C, our results demonstrate
that compound 5 can increase Chk2-T68 phosphorylation,
suggesting that it could induce DSBs and activate the ATM−
Chk2 pathway. This is an interesting diﬀerence between
compound 5 and the positive control protoapigenone, a p-
quinol ﬂavonoid, which did not inﬂuence the ATM-dependent
phosphorylation of Chk2 in accordance with our previous
ﬁndings.19
pcm was reported as a potent dietary antioxidant, counter-
acting lipid peroxidation in rat liver microsomes with an
inhibitory concentration (IC50) value of 0.4 μM.
26 Furthermore,
a recently published spectroscopic study on the in vitro
antioxidant activity of p-coumaric acid indicated that it can
eﬃciently scavenge 2,2-diphenyl-1-picrylhydrazyl, 2,2′-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid), superoxide anion,
and H2O2, as well as prevent the autoxidation of linoleic acid.
27
As these antioxidant mechanisms are unlikely to be disturbed by
the ester function pcm, similar activities can reasonably be
expected from pcm as well. Accordingly, our next aim is to
investigate whether or not the identiﬁed bioactive metabolites
have the chance to form through ROS scavenging by pcm. In
order to assess this, we studied the •OH radical-scavenging
activity of pcm.
•OH Radical-Scavenging Activity of pcm. The •OH
radical-scavenging capacity of pcm was performed by measuring
the inhibition of the oxidative damage caused to 2-deoxy-D-
ribose by Fenton reaction. A free-radical trapping antioxidant,
NXY-059 (disufenton sodium; Cerovive), was used as positive
control; this compound reached phase III clinical trials as a
neuroprotective agent.28 We found that pcm is a stronger •OH
radical scavenger (IC50 = 0.345 [95%C.I. 0.313−0.380] mM) in
this bioassay than NXY-059 (IC50 = 1.826 [95% C.I. 1.501−
2.220] mM). The results obtained for NXY-059 were in good
agreement with those of our previous study.29
In Vitro Antitumor Activity of pcm in the Presence of
H2O2-Induced Oxidative Stress.MCF-7 cells were subjected
to a combined treatment with pcm and H2O2, aiming to
investigate whether or not externally provoked oxidative stress
can modulate sensitivity of cells toward pcm (Table 3).
Synergism could clearly be observed between pcm and H2O2,
particularly at higher rates of inhibition that are more important
in terms of antitumor activity.30 Moreover, there seems to be a
tendency in favor of higher H2O2 versus pcm ratios, further
strengthening the assumption that this phenomenon might be
connected to the formation of oxidized metabolites of pcm
proportionally to the level of oxidative stress. It is worth
mentioning that pcm was found stable for at least 92 h when
dissolved in MeOH (1 mg/mL) and 400 μL of hydrogen
peroxide (30%) was added [for high-performance liquid
chromatography (HPLC)−photometric diode array (PDA)
chromatogram, see Supporting Information, Figure S1]. This
indicates that the observed increase in the cytotoxic activity is
not due to a simple chemical reaction between H2O2 and pcm.
Fenton Reaction of pcm. With an attempt to model the
eﬀect of oxidative stress on pcm in terms of providing possible
metabolites, pcm was subjected to Fenton reaction, which is
well-known to provide excess •OH radicals. Following pre-
puriﬁcation with solid phase extraction on silica, the presence of
compound 5 was detected in the reaction mixture by reversed-
phase-HPLC and HPLC−MS (for the ﬁngerprint chromato-
grams and LC−MSdata, see Supporting Information, Figures S2
and S3). This clearly demonstrates that compound 5 can form
when pcm scavenges hydroxyl radicals. However, it is worth
Table 3. Interaction between pcm and H2O2 Concerning
Their Cytotoxicity on MCF7 Cellsa
H2O2
vs pcm CI50 CI75 CI90 Dm m r CIavg
2.5:1 0.79 0.60 0.45 247.66 2.109 0.985 0.556
1.25:1 0.93 0.60 0.39 250.18 3.197 0.988 0.550
0.625:1 1.06 0.68 0.44 222.79 3.610 0.974 0.623
aCI values are given at 50, 75, and 90% of cytotoxicity (ED50, ED75,
and ED90, respectively). CIavg: weighted average CI value; CIavg =
(CI50 + 2CI75 + 3CI90)/6. CI < 1, CI = 1, and CI > 1 represent
synergism, additivity, and antagonism, respectively. Dm, m, and r
represent antilog of the x-intercept, slope, and linear correlation
coeﬃcient of the median eﬀect plot, respectively.30 Stability of pcm in
the presence of H2O2 (see Figure S1 in the Supporting Information)
suggests that the interaction is not due to a chemical reaction between
them.
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mentioning that the extreme oxidative conditions provided by
Fenton’s reaction do not allow to draw any further quantitative
conclusion about the formation of metabolites that could rise in
a biological environment when hydroxyl radical (or possibly
other types of ROS) scavenging takes place. In order to obtain a
deeper insight into the potential relevance of compound 5
formation upon ROS scavenging, in silico studies were
performed by means of density functional theory calculations.
In Silico Studies about the Formation of pcm
Metabolites in the Presence of •OH Radicals. In the
presence of highly reactive species such as •OH free radical, pcm
may be oxidized following two mechanical sequential chemical
pathways (see Figure 3). Mechanism 1 is initiated by •OH
addition at various positions, leading to the formation of the
corresponding radical adducts that are then stabilized by H-
atom abstraction. Mechanism 2 is initiated by H-atom
abstraction, forming a radical which then undergoes •OH
addition at various positions, forming the corresponding
adducts. It is important to note that compound 3 can only be
obtained from mechanism 2, whereas compound 5 can be
obtained from both mechanisms 1 and 2. A description of these
mechanical pathways and the calculated thermodynamic
analysis are shown in Figure 3.
Regardless of the mechanism, all predicted compounds are
thermodynamically favorable with respect to the parent
compound (pcm) because every single step exhibits negative
Gibbs energies (Figure 3B). The calculated global thermody-
namics shows that cm and pcm−OH are the most favorable
compounds (ΔG being −105.8 and −104.7 kcal·mol−1,
respectively), while 5 appears much less stable (ΔG = −75.2
kcal·mol−1), which can be easily explained by the loss of
aromaticity. It must be stressed that only compounds 5, cm, and
3 were experimentally identiﬁed among those that can be
formed through the above mechanisms. Therefore, joint
experimental observations and calculations suggest the
important role of kinetics to allow the formation of the least
thermodynamically favorable compounds such as 5.
Figure 3. Reactivity of pcm in the presence of •OH radical (A) and thermodynamics of the reaction steps (B). HAT: hydrogen atom transfer; q-pcm
and q-cm represent quinone forms of pcm and cm, respectively. Framesmark species observed experimentally from the Fenton reaction of pcm and/or
from its oxidation with PIFA. Bond dissociation enthalpy (BDE) is deﬁned as the enthalpy required to the homolytic cleavage of X−Hbond as follows:
BDE(R−H) =H(R•, 298 K) +H(H•, 298 K)−H(R−H, 298 K), whereH is the enthalpy. O−H and C−HBDE values for each HAT are given in red
and blue, respectively, in kcal·mol−1. Gibbs energies (ΔG, kcal·mol−1) are indicated for each reaction step relative to that of pcm. Evidence for the
formation of compound 5 from the Fenton reaction of pcm is shown in the Supporting Information, Figures S2 and S3.
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Mechanism1. Focusmust be given to theOH-addition step,
which may occur at several C-atom positions, which drives
regioselectivity in the adduct formation. Additions on the
aromatic ring, that is, positions C1′ and C3′ (see Figure 3A for
numbering of pcm) can be predicted by the electronic eﬀect of
the OH group at p-position, leading to [5−OH]• and [cm−
OH]•. Such additions are only slightly favorable because of the
loss of aromaticity (ΔG being −4.0 and −8.9 for C1′ and C3′
OH-additions, respectively). The higher stability of [cm−OH]•
as compared to [5−OH]• may be explained by the lower
geometrical disruption with the side chain while spin density
distributions are similar for the two radicals (Figure 4).
Interestingly, OH-additions at C2 and C3 (leading to [pcm−
OH]• and [pcm−OH′]•) are signiﬁcantly favored over those
taking place at C1′ or C3′. Spin density distributions (Figure 4)
in [pcm−OH]• and [pcm−OH′]• underline the much lower
stabilization of single electron with respect to [5−OH]• and
[cm−OH]•. However, the loss of aromaticity is energetically
more expensive, which somehow explains the more favorable
OH-addition on the C−C double bond than on the aromatic
ring. The addition at C2 and thus the formation of [pcm−OH]•
is the most favorable owing to the slightly more stabilizing
delocalization of free radical thanks to the aromatic ring (Figure
4A).
The second step of mechanism 1 is a simple H-atom
abstraction driven by the O−H BDEs (see Figure 3A). The
lower the BDE, the higher the likelihood of the X−Hbreaking. It
must be stressed that one or two H-atom abstractions may be
considered, depending on the adduct. For instance, in [5−OH]•
and [pcm−OH′]•, only OH and C3−H bonds are expected to
be broken, respectively. It must be stressed that experimental
observations suggest that the C−C bond is broken in [pcm−
OH′]• allowing rearrangement leading to 3.
Interestingly, in [cm−OH]• and [pcm−OH]•, the H-atom
may be abstracted from either the phenolic O−H moiety or the
C−H bond bearing the new OH-group (i.e., C1′ and C2 for
[cm−OH]• and [pcm−OH]•, respectively). The calculations
exhibit very low BDEs (21.0−59.0 kcal·mol−1), suggesting that
H-abstraction is not the limiting step of this process. It must be
stressed that C−H BDEs of both [cm−OH]• and [pcm−OH]•
are systematically lower than that of O−H, as the former allows
turning back to aromatic systems. In the case of OH abstraction,
a tautomeric step is required to reach the ﬁnal products cm and
pcm−OH. However, such event is known to be fast and
thermodynamically favorable. Therefore, the observed diﬀer-
ence between BDE(O−H) and BDE(C−H) values is not
expected to play a crucial role in protic environments.
Mechanism 2. Polyphenols are known to undergo H-atom
abstraction from their phenolic OH groups. Here, OH-BDE is
−82.9 kcal·mol−1 (see Figure 3A), which lies within the typical
range of polyphenol BDEs.31−34 The H-atom abstraction leads
to the formation of pcm−[H]• free radical that can undergo
OH-addition (second step of mechanism 2). In contrast to the
OH-addition on pcm, this step is more energetically favorable as
the products turn back to closed-shell species. The regiose-
lectivity of OH-addition is driven by both thermodynamics and
kinetics. On the one hand, thermodynamics suggests that
addition preference is at C1′ < C3′ < C2, ΔG being −38.3,
−42.4, and −45.8 kcal·mol−1 for addition at C1′, C3′, and C2,
respectively (see Figure 3B). On the other hand, the kinetics is
correlated to the spin density distribution of pcm−[H]• (Figure
4). The higher spin density at C1′ suggests that OH-addition at
this position is faster, rationalizing the formation of 5. In other
words, calculations suggest that 5 is the kinetic product while q-
cm and q-pcm−OH are the thermodynamic ones. Again,
tautomeric steps of q-cm and q-pcm−OH are not expected to
play a key role in the global view of such mechanical pathways.
Competition between Mechanisms 1 and 2. Interest-
ingly, the competition between mechanisms 1 and 2 is a matter
of competition between H-atom abstraction and OH-addition
on pcm. Thermodynamically, H-atom abstraction from p-OH
(ΔG =−36.9 kcal·mol−1, Figure 3B) is more favorable thanOH-
addition at any possible position by at least −14.7 kcal·mol−1.
Therefore, the major pathway likely starts with H-atom
abstraction (mechanism 2). Moreover, this explains the
experimentally observed formation of cm and 5; the former
being the global thermodynamic product while the latter is a
kinetic product from the OH-addition step. It is important to
note that the experimental observation of 3 as a product again
suggests the importance of kinetics. Such a product can be
formed only via the alternative mechanism 1, that is, OH-
addition at C2 and thus via [pcm−OH′]•. The •OH radical is
known to be very reactive and nonspeciﬁc, also highlighting
certain stochasticity in the reactivity. However, it must be
stressed that the higher Gibbs energies of OH-addition at C1′
and C3′ suggest that OH-addition on the aromatic ring is very
unlikely.
It must be noted that although theoretical calculations suggest
cm as a major product, it has only been observed from the PIFA-
mediated oxidation and not from the Fenton reaction of pcm.
This can likely be explained by the fact that the catechol moiety
of cm might make it particularly sensitive to further oxidation,
leading to a rapid decomposition and consequential diﬃculties
of detection under the harsh experimental conditions
represented by the Fenton reaction. In addition to this, the
presence of an alternative product 4 cannot be fully explained by
the proposedmechanism. One can only suspect the formation of
an epoxide intermediate and subsequent ring opening as an
explanation of the migration of the p-hydroxyl group resulting in
the hydroquinone derivative 4.
Figure 4. Spin density distribution of the radicals formed by the
reaction between pcm and •OH radicals. (A) Radicals formed through
OH-addition, and (B) radicals formed through hydrogen atom
abstraction. Blue and red spheres depict positive and negative atomic
spin densities, respectively.
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■ CONCLUSIONS
By processing various oxidized mixtures of pcm, two active
metabolites were identiﬁed from mixtures with the highest
antitumor potential. In particular, compound 5 (graviquinone)
was revealed as a prospective lead compound, with an ability to
bypass multidrug resistance mediated by the ABCB1 trans-
porter, in a lymphoma cell line transfected with ABCB1 gene
and anMDRnon-small-cell lung cancer cell line established after
continuous exposure to doxorubicin. Compound 5 showed a
remarkable selectivity toward cancer cells in respect to DNA
damage induction. DNA damaging activity of compound 5 was
accompanied by its ability to interfere with components of the
ATR signaling pathway.
Concerning the possible biological role of compound 5, our in
vitro and in silico studies strongly suggest that it can be formed
as a kinetic product when its parental antioxidant, pcm,
scavenges ROS. The mild in vitro antitumor eﬀect of pcm was
signiﬁcantly increased in the presence of H2O2-induced
oxidative stress, and Fenton’s reaction clearly conﬁrmed that
the formation of compound 5 from pcm is possible upon •OH
radical scavenging. Our results provide indirect evidence for the
transformation of pcm to compound 5 in a biological system
facing oxidative stress. The herein described phenomenon also
suggests that the oxidative stress-related metabolites of
antioxidants represent a segment of chemical space that is rich
in valuable bioactive compounds. This would warrant systematic
studies on such metabolites as a possible novel drug discovery
strategy.
■ EXPERIMENTAL SECTION
Chromatography. Analytical HPLC was performed on a gradient
system of two PU-2080 pumps connected to an MD-2010 Plus
photodiode array detector (Jasco Analytical Instruments, Tokyo,
Japan), on a Kinetex XB-C18 (5 μm, 100 Å, 250 × 4.6 mm) column
with solvent system 1. Semipreparative HPLC was performed on a
system of two Waters 600 pumps connected to a Waters 600 2λ
detector (Waters, Milford, Massachusetts, USA), on a Kinetex XB-C18
(5 μm, 100 Å, AX, 250 × 21.2 mm) column. HPLC−MS analysis was
performed on an Agilent 1200 liquid chromatography system, including
a binary pump, a column temperature controller, and a diode array
detector (DAD), connected to a 6410 triple quadrupole mass
spectrometer (QQQ-MS) equipped with an electrospray ionization
(ESI) source (Agilent Technologies, Palo Alto, CA, USA). The analysis
was carried out at 45 °C on a Kinetex EVO C18 (2.6 μm, 50 × 3.0 mm,
Phenomenex) column with solvent system 2 at a ﬂow rate of 1.25 mL/
min.
Solvent system 1: gradient of ACNfrom 30 to 70% in water at 0−
12 min, 70% of ACN at 12−14 min, then back to 30% of ACN, and the
total running time was 25 min.
Solvent system 2: gradient of 2−100% B at 0−5.9 min, 100% of B at
5.9−7.0, from 7.01 min back to 2% of B. Eluent A was 0.1% (v/v)
triﬂuoroacetic acid (TFA) in water, and eluent B was 0.1% TFA in the
mixture of ACN−water (95:5).
Flash chromatography was performed on CombiFlash Rf+ (Tele-
dyne ISCO)with Solvent system 3: a gradient of ethyl acetate from 0 to
100% in n-hexane.
Oxidation of pcm for Screening. As a preliminary experiment,
pcm was oxidized under diﬀerent conditions. pcm (10.0 mg) was
dissolved in 10 mL of ACN (OX1), ACN−water (9:1, v/v) (OX2),
MeOH (OX3), MeOH−water (9:1, v/v) (OX4), or dichloromethane
(OX5). A quantity of PIFA (48.3 mg, 2 equiv) (OX1-4) or PCC (18.1
mg, 1.5 equiv) (OX5) was added. The reactions were monitored by
thin-layer chromatography (TLC) and stopped after 1−4 h, evaporated
under vacuum, adsorbed onto 2.0 g of silica, layered on the top of 2.5 g
of silica, eluted with 100 mL of EtOAc, and evaporated under vacuum.
Each reaction mixture was redissolved in MeOH and analyzed by
HPLC, using solvent system 1 at a ﬂow rate of 1 mL/min.
Scale-Up Oxidations I and II. The starting material pcm [500 mg
(A), 200 mg (B)] was dissolved in anhydrous ACN [50 mL (A)], or in
ACN−water [9:1, v/v, 10 mL (B)], and a quantity of PIFA [2 equiv,
2413.3 mg (A), 965.3 mg (B)] was added to the solutions with
continuous stirring and heating on 60 °C (A). After 5 h (A), or 8 h (B),
the reaction mixtures were evaporated, redissolved in MeOH, and
adsorbed onto 12 g of silica. The reaction mixtures were puriﬁed by
ﬂash chromatography (CombiFlash Rf+) on a silica column (RediSep,
24 g), using a dry-loading technique and solvent system 3 at a ﬂow rate
of 35 mL/min. During the purifying process, 233 fractions (A) and 177
fractions (B) were collected and combined based on their TLC
ﬁngerprints. Fractions 46 to 52 (A) gave compound 1 in pure form
(19.8 mg). From fractions 109 to 116 (A), compound 2 was puriﬁed
with the help of preparative HPLC, using an isocratic elution (45%
ACN), detected on 320 nm, and 5.0 mg was obtained. From fractions
57 to 65 (B), compound 3 was puriﬁed with the help of preparative
HPLC, using an isocratic elution (28% ACN), detected on 280 nm, and
6.0 mg was obtained. From fractions 88 to 98 (B), compound 4 was
puriﬁed with the help of preparative HPLC, using an isocratic elution
(30% ACN), detected on 280 nm, and 18.9 mg was obtained. All the
puriﬁed compounds (1−4) were analyzed by HPLC to check their
purity.
Scale-Up Oxidation III. An initial attempt for obtaining compound
5 from pcm (200 mg in 200 mL of ACN) by using 2 equiv of PIFA led
to an isolated yield as low as 2.43% after puriﬁcation with ﬂash
chromatography and subsequent HPLC. With an aim to increase the
yield, the oxidation was repeated with phenyliodine diacetate (PIDA)
as follows. After dissolving pcm (200mg) in ACN−water (9:1, v/v, 200
mL), PIDA (723.0 mg, 2 equiv) was added to the solution with
continuous stirring. After 1 h, the reaction was stopped, evaporated
under vacuum, and adsorbed onto 3.0 g of Celite 545. The reaction
mixture was processed through ﬂash chromatography on a silica
column (RediSep Gold, 12 g), using dry-loading technique and solvent
system 3 at a ﬂow rate of 30 mL/min. Ninety-ﬁve fractions were
collected and combined based on their TLC ﬁngerprints. Compound 5
was puriﬁed from fractions 50 to 55 with preparative HPLC (isocratic
elution with 42% aqueous ACN), and 43 mg (yield 19.73%) was
obtained.
Compound Characterization Data. Compounds 1−5 possessed
a purity of >95% by means of HPLC−DAD.
High-resolutionMS (HRMS) andMS−MS analyses were performed
on a Thermo Velos Pro Orbitrap Elite (Thermo Fisher Scientiﬁc)
system. The ionization method was ESI operated in positive ion mode.
The protonated molecular ion peaks were fragmented by CID at a
normalized collision energy of 35%. For the CID experiment, helium
was used as the collision gas. The samples were dissolved in methanol.
The protonated molecular ion peaks were fragmented by CID at a
normalized collision energy of 35%. Data acquisition and analysis were
accomplished with Xcalibur software version 2.0 (Thermo Fisher
Scientiﬁc).
NMR spectra of compounds 1, 2, 3, and 5were recorded on a Bruker
Avance NEO 500 MHz spectrometer equipped with a Prodigy BBO 5
mm CryoProbe. Compounds 1, 2, and 5 were dissolved in acetone-d6,
and methanol-d4 was used for 3 (VWR Chemicals, Belgium). Standard
1D and 2D spectra were processed with MestReNova v6.0.2-5475
software.
NMR spectra of compound 4were recorded at 25 °Con a Varian 800
MHz spectrometer equipped with a 13C sensitivity-enhanced salt
tolerant 1H/13C/15N cryogenically cooled probe head. The sample was
dissolved in methanol-d4 (Eurisotop, France). Standard 1D and 2D
spectra were acquired using pulse sequences available in the VNMJ 3.2
library. Chemical shifts are reported in the delta scale using residual
solvent signals (methanol-d4: 3.31 or 49.15 ppm, acetone-d6: 2.05 or
29.84 for 1H or 13C, respectively) as references. For spectral analysis
and data reporting, the ACD/NMRWorkbook 2015.2.9. software suite
(ACD/Labs, Canada) was used.
Compound 1. 1H NMR (500 MHz, acetone-d6): δ 8.56 (1H, s, H-
2), 8.28 (1H, d, J = 1.4 Hz, H-4), 7.82 (1H, d, J = 16.1 Hz, H-9), 7.79
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(1H, dd, J = 8.7, 1.4Hz, H-6), 7.68 (1H, d, J = 8.7Hz, H-7), 6.58 (1H, d,
J = 16.1 Hz, H-10), 3.94 (3H, s, 8-OCH3), 3.77 (3H, s, 11-OCH3);
13C
NMR (125 MHz, acetone-d6): δ 167.5 (C-11), 163.7 (C-8), 157.4 (C-
7a), 153.4 (C-2), 145.2 (C-9), 132.0 (C-5), 126.3 (C-6), 126.2 (C-3a),
123.0 (C-4), 118.6 (C-10), 115.4 (C-3), 113.3 (C-7), 52.0 (8-OCH3),
51.8 (11-OCH3). HRMS: M + H = 261.07572 (δ = −0.1 ppm;
C14H13O5). HR-ESI-MS-MS (CID = 35%; rel. int. %): 247(2);
229(100); 215(7); 197(3).
Compound 2. 1H NMR (500 MHz, acetone-d6): δ 7.53 (1H, d, J =
15.9 Hz, H-3), 7.15 (1H, br s, H-5), 7.04 (1H, dd, J = 8.2, 1.2 Hz, H-9),
6.86 (1H, d, J = 8.2 Hz, H-8), 6.27 (1H, d, J = 15.9 Hz, H-2), 3.71 (3H,
s, 1-OCH3). HRMS: M + H = 195.06520 (δ = 0.1 ppm; C10H11O4).
HR-ESI-MS-MS (CID = 35%; rel. int. %): 167(15); 163(100);
153(11); 138(25).
Compound 3. 1H NMR (500 MHz, methanol-d4): δ 9.76 (1H, s, H-
7), 7.76 (2H, d, J = 8.6 Hz, H-2, H-6), 6.91 (2H, d, J = 8.6 Hz, H-3, H-
5); 13C NMR (125 MHz, methanol-d4): δ 192.8 (C-7), 165.2 (C-4),
133.4 (C-2, C-6), 130.3 (C-1), 116.9 (C-3, C-5). HRMS: M + H =
123.04399 (δ = −0.5 ppm; C7H7O2). HR-ESI-MS-MS (CID = 35%;
rel. int. %): 95(100).
Compound 4. 1H NMR (800MHz, methanol-d4): δ 7.93 (1H, d, J =
16.2 Hz, H-3), 6.90 (1H, d, J = 2.6 Hz, H-9), 6.66−6.74 (2H, m, H-6,
H-7), 6.49 (1H, d, J = 16.1 Hz, H-2), 3.77 (3H, s, OCH3);
13C NMR
(201 MHz, methanol-d4): δ 170.0 (C-1), 151.7 (C-5), 151.4 (C-8),
142.3 (C-3), 122.9 (C-4), 120.4 (C-7), 118.0 (C-2), 117.8 (C-6), 114.8
(C-9), 52.2 (OCH3). HRMS: M + H = 195.06522 (δ = 0.04 ppm;
C10H11O4). HR-ESI-MS-MS (CID = 35%; rel. int. %): 167(3);
163(100); 153(9); 138(1).
Compound 5. 1H NMR (500 MHz, acetone-d6): δ 6.85 (2H, d, J =
10.0 Hz, H-3, H-5), 6.68 (1H, d, J = 15.7 Hz, H-7), 6.23 (1H, d, J = 15.7
Hz, H-8), 6.16 (2H, d, J = 10.0 Hz, H-2, H-6), 3.70 (3H, s, 9-OCH3).
HRMS:M +H= 195.06512 (δ =−0.07 ppm; C10H11O4). HR-ESI-MS-
MS (CID = 35%; rel. int. %): 181(5); 167(30); 163(100); 153(9);
135(15); 107(5).
Chemicals. RPMI 1640 medium, Dulbecco’s modiﬁed Eagle’s
medium (DMEM), fetal bovine serum (FBS), antibiotic−antimycotic
solution, penicillin−streptomycin solution, L-glutamine, and trypsin/
ethylenediaminetetraacetic acid (EDTA) were purchased from Bioind,
Beit Haemek, Israel. MTT was purchased from Sigma, St. Louis, MO,
USA. Dimethyl sulfoxide (DMSO) was obtained from Sigma-Aldrich
Chemie Gmbh, Germany. The annexin-V-FITC (AV) apoptosis
detection kit with PI was purchased from Abcam, Cambridge, UK.
DHE was obtained fromMolecular Probes, Invitrogen, USA. Phospho-
histone H2A.X antibody and secondary antibody Alexa Fluor 488 goat
anti-rabbit IgG (H + L) were purchased from Cell Signaling
Technology Inc. (Danvers, Massachusetts, USA). Doxorubicin solution
was obtained from Ebewe Arzneimittel GmbH. CDDP was obtained
from Pﬁzer (Perth) Pty Ltd. Both drugs were diluted in sterile water
prior treatment.
Cells and Cell Culture.Twomouse lymphoma cell lines were used:
L5178 mouse T-cell lymphoma cells (ECACC catalog number
87111908, U.S. FDA, Silver Spring, MD, U.S.) and an MDR
(L5178B1) cell line derived from L5178 by transfection with pHa
MDR1/A retrovirus.35 Cells were cultured in McCoy’s 5A media
supplemented with nystatin, L-glutamine, penicillin, streptomycin, and
inactivated horse serum, at 37 °C and 5% CO2. L5178B1 cell line was
selected by culturing the infected cells with 60 μg/L of colchicine
(Sigma).
NCI-H460, A549, NCI-H661, and SiHa cell lines were purchased
from the American Type Culture Collection, Rockville, MD. HaCaT
cell line was obtained from CLS-Cell Lines Service, Eppelheim,
Germany. NCI-H460/R cells were selected originally from NCI-H460
cells after 3 months of doxorubicin selective pressure.36 The HeLa and
MCF-7 cell lines were purchased from Bioresource Collection and
Research Center, BCRC, Taiwan.
NCI-H460, NCI-H460/R, A549, and NCI-H661 cell lines were
maintained in RPMI 1640medium supplemented with 10% FBS, 2mM
L-glutamine, 10 000 U/mL of penicillin, 10 mg/mL of streptomycin,
and 25 μg/mL of amphotericin B solution, while HaCaT cells were
cultured in DMEM supplemented with 10% FBS, 2 mM L-glutamine,
4.5 g/L of glucose, 5000 U/mL of penicillin, and 5 mg/mL of
streptomycin solution at 37 °C in a humidiﬁed 5%CO2 atmosphere. All
adherent cell lines were subcultured at 72 h intervals using 0.25%
trypsin/EDTA and seeded into a fresh medium at the following
densities: 8000 cells/cm2 for NCI-H460, NCI-H460/R, and HaCaT
and 16 000 cells/cm2 for H661. MCF-7, HeLa, and SiHa cell lines were
maintained inDMEM(Sigma-Aldrich) supplemented with 10% FBS, L-
glutamine, and 4500 mg/L of glucose. These cells were cultured at 37
°C in a humidiﬁed 5% CO2 incubator (NuAire).
Cytotoxicity by MTT Assay. Cell viability was assessed by MTT
assay.37 In the case of L5178 and L5178B1 cell lines, 6 × 10
3 cells were
added into 96-well ﬂat-bottom microtiter plates, treated with the
samples, and incubated for 72 h. Adherent cells grown in 25 cm2 tissue
ﬂasks were trypsinized, seeded into ﬂat-bottomed 96-well tissue culture
plates (1000 cells/well for the NCI-H460, NCI-H460/R, A549, and
HaCaT cell lines, 2000 cells/well for the NCI-H661 cell line), and
incubated overnight in 100 μL of the appropriate medium. After 24 h,
the cells were treated with compound 4 (1−20 μM) or 5 (1−20 μM)
and incubated for 72 h.
At the end of the incubation period,MTTwas added to each well in a
ﬁnal concentration of 0.2 mg/mL for 4 h, as described previously.20
Formazan product was extracted from cells by DMSO, and the
absorbance was measured at 540 nm using an automatic microplate
reader (LKB 5060-006 Micro Plate Reader, Vienna, Austria). The
values obtained for samples treated with 4 and 5 were corrected with
those of blank samples treated with the compounds’ solvent DMSO at a
maximal concentration of 1.5% v/v. IC50 values were deﬁned as the
concentration of the drug that inhibited cell growth by 50% and
calculated by nonlinear regression analysis usingGraphPad Prism 6. For
calculated IC50 values, see Table 1.
Cell Death Analysis. The percentages of apoptotic, necrotic, and
viable cells were determined by AV/PI labeling. All cell lines were
incubated overnight in adherent six-well plates (100 000 cells per well
for NCI-H460, NCI-H460/R, A549, and HaCaT cell lines, 200 000
cells per well for NCI-H661 cell line) and then subjected to single
treatments with 10 μM compound 4 or compound 5. Treatment with
40 nM doxorubicin was used as positive control in NCI-H460 and
HaCaT cells. After 24 h, total (attached and ﬂoating) cells were
collected. The cell pellet was resuspended in 50 μL of binding buﬀer
containing AV and PI in a ratio of 1:1 (v/v). After the incubation period
(10 min at room temperature in the dark), 1 mL of phosphate-buﬀered
saline (PBS) was added and AV/PI staining was analyzed within 1 h by
ﬂow cytometry.
The ﬂuorescence intensity of AV (FL1-H channel) and PI (FL2-H
channel) was measured on a CyFlow Space ﬂow cytometer (Partec,
Münster, Germany). A minimum of 10 000 events were assayed for
each sample. Percentages of viable (AV− PI−), early apoptotic (AV+
PI−), apoptotic, and necrotic (AV+ PI+) and dead (AV− PI+) cells
were analyzed.
Flow Cytometry. All cell lines were incubated overnight in
adherent six-well plates (100 000 cells per well for NCI-H460, NCI-
H460/R, A549, and HaCaT cell lines, 200 000 cells per well for NCI-
H661 cell line) and then subjected to single treatments with 10 μM
compound 4 or 5 that lasted 24 h. Treatment with 2 μM CDDP was
used as positive control.
To detect double-strand DNA breaks, cells were labeled with
phospho-histone H2A.X (Ser139) antibody coupled with secondary
antibody Alexa Fluor 488 goat anti-rabbit IgG (H + L). Adherent cells
were harvested by trypsinization, washed twice in PBS, and ﬁxed in 4%
paraformaldehyde for 10 min at room temperature. Cells were then
permeabilized by adding ice-cold 90% methanol and stored at −20 °C
overnight. After washing in PBS, cells were blocked for 60 min with
0.5% bovine serum albumin in PBS. Cells were then resuspended in 100
μL of primary antibody diluted in 0.5% bovine serum albumin (1:1000)
and incubated for 60 min at room temperature. After washing in PBS,
cells were resuspended in 100 μL of secondary antibody (1:1000) and
incubated for 30 min at room temperature.
To detect ROS level, cells were stained with superoxide indicator
DHE. Adherent cells were harvested by trypsinization and incubated in
medium with 1 mM DHE for 30 min at 37 °C in the dark.
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Prior to ﬂow cytometry analysis, cells were subsequently washed and
resuspended in 1 mL of PBS. The ﬂuorescence intensity of phospho-
histone H2A.X (Ser139) antibody coupled with secondary antibody
(FL1-H channel) and DHE (FL2-H channel) were measured on
CyFlow Space ﬂow cytometer (Partec, Münster, Germany). A
minimum of 10 000 events were assayed for each sample.
DDR Studies.MCF7 cells were incubated overnight in adherent 60
mm culture dish (700 000 cells per dish) and then pretreated with 10
μM compound 5 or pcm for 30 min. Treatment with 10 μM
protoapigenone was used as positive control. After this, they were
exposed to UV irradiation (10 J/m2) in the following 1 h to induce
DDR. Protein collection and western blot assays were performed in
accordance with the method described by our previous study.19
Proteins of the cells were extracted with lysis buﬀer (1 mM EDTA, 10
mM tris(hydroxymethyl)aminomethane, pH 7.5, 0.5% NP-40, 10%
glycerol, and 420 mM NaCl) supplemented with a cocktail of protease
and phosphatase inhibitor (Roche Applied Science) and 1 mM DL-
dithiothreitol. After sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis, the separated proteins in the gel were electrophoretically
transferred to nitrocellulose membranes. The membranes with the
transferred proteins were detected using speciﬁc primary antibodies
followed by horseradish peroxidase-coupled secondary antibodies
(Jackson ImmunoResearch) and then recognized by enhanced
chemiluminescence reagent (Millipore). Images were captured with a
LAS-4000 luminescent image analyzer system (Fujiﬁlm). The primary
antibodies against Chk1-S345 and Chk2-T68 were purchased fromCell
Signaling Technology (Danvers, USA); Chk1, Chk2, and β-actin were
purchased from Santa Cruz. The β-actin expression served as an
internal control.
Hydroxyl Radical-Scavenging Activity. The •OH-scavenging
capacity of the investigated compounds (pcm, and NXY-059 as positive
control) were performed by measuring the inhibition of damage to 2-
deoxy-D-ribose by Fenton reaction.38 Assays were carried out in 50 mM
3-(N-morpholino)propanesulfonic acid buﬀer, pH 6.0, containing 2.8
μM 2-deoxy-D-ribose, and increasing concentrations (0.002−5 mM) of
samples to which 0.2 μMH2O2 and 1.5 μM FeSO4 were added to start
the reaction (in total volume of 280 μL). Then, after 3 min of
incubation at 37 °C, during which period of time •OH formation was
linear, TBA reactivity was developed by heating at 100 °C for 15 min
after adding 400 μL of a mixture containing 15% (w/v) trichloroacetic
acid, 0.25 M HCl, 0.325% (w/v) TBA, and 0.06 M NaOH. The
resulting chromogens were measured at a wavelength of 532 nm against
appropriate blanks.39
Combination Assay on the Cytotoxicity of pcm and H2O2. A
checkerboard microplate method was applied to study the interaction
between pcm and H2O2 concerning their cytotoxicity on MCF7 cells.
Cells (1 × 104) were seeded to each well in a 96-well plate. The plates
were incubated at 37 °C for 24 h. Standard solution of H2O2 (Sigma-
Aldrich) and pcm were stored at −20 °C until use. The stock solutions
and serial twofold dilutions of each drug were prepared according to the
recommendations of several ﬁx pcm vs H2O2 ratios to testing. pcm was
serially diluted along the ordinate, while H2O2 was diluted along the
abscissa. A total volume of 100 μL (including pcm and H2O2) was
distributed into each well of the microdilution plates. The plates were
incubated at 37 °C for 48 h, and then MTT solution was added to each
well. After incubation at 37 °C for 4 h, the MTT-containing medium
was removed, and 100 μL of DMSOwas added to dissolve the formazan
crystals. Cell viability was determined by measuring the optical density
values (absorbance) of the chromogenic product at 550 nm with an
enzyme-linked immunosorbent assay reader (Thermo Multiskan
Ascent). Three plates were prepared on three diﬀerent days, and
averages of these three replicates were utilized to calculate the
combination index (CI) values at several ﬁx pcm vs H2O2 ratios by
using the CalcuSyn software.
In Silico Calculations. Calculations were performed with the
Gaussian09 package (Rev. A). Ground-state geometries were optimized
using the B3P86 functional that has been shown to properly reproduce
thermodynamics of polyphenol oxidative processes. The double-ζ basis
set 6-31+G(d,p) was used to describe C-, O-, and H-atoms.
Calculations were performed including solvation polarization eﬀects
by using conductor-like polarizable continuum model. Frequency
calculations were performed to ensure that the obtained geometries
were in the global minimum of the potential energy surface, as pictured
by the absence of any imaginary frequency. Mulliken spin density
visualization has been carried out using the VMD program.
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■ ABBREVIATIONS
pcm, p-coumaric acidmethyl ester; cm, caﬀeic acidmethyl ester;
fm, ferulic acid methyl ester; GI50, 50% growth inhibitory
concentration; PIFA, phenyliodine bis(triﬂuoroacetate); BCRP,
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breast cancer resistance protein; SEM, standard error of mean;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide; H2A.X, histone 2A.X; ATR, ataxia telangiectasia and
Rad3-related kinase; ATM, ataxia telangiectasia mutated kinase;
FA, Fanconi anemia; DSBs, DNA double-strand breaks; DPPH,
2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2′-azino-bis(3-ethyl-
benzothiazoline-6-sulphonic acid); 95% C.I., 95% conﬁdence
interval; CI, combination index; CIavg, weighted average CI
value; PDA, photometric diode array; SET, single-electron
transfer; SPE, solid-phase extraction; HAT, hydrogen atom
transfer; BDE, bond dissociation enthalpy; ACN, acetonitrile;
PIDA, phenyliodine diacetate; DMEM, Dulbecco’s modiﬁed
Eagle’s medium; FBS, fetal bovine serum; AV, annexin-V-FITC;
PI, propidium iodide; DHE, dihydroethidium; PBS, phosphate-
buﬀered saline; DDR, DNA damage response; HRP, horse-
radish peroxidase; ECL, enhanced chemiluminescence; MOPS,
3-(N-morpholino)propanesulfonic acid; TBA, thiobarbituric
acid; C-PCM, conductor-like polarizable continuum model
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Fischer, J. Nitrone derivatives of trolox as neuroprotective agents.
Bioorg. Med. Chem. Lett. 2005, 15, 3012−3015.
(30) Chou, T.-C. Theoretical basis, experimental design, and
computerized simulation of synergism and antagonism in drug
combination studies. Pharmacol. Rev. 2006, 58, 621−681.
(31) Trouillas, P.; Fagner̀e, C.; Lazzaroni, R.; Calliste, C.; Marfak, A.;
Duroux, J.-L. A theoretical study of the conformational behavior and
electronic structure of taxifolin correlated with the free radical-
scavenging activity. Food Chem 2004, 88, 571−582.
(32) Trouillas, P.; Marsal, P.; Siri, D.; Lazzaroni, R.; Duroux, J.-L. A
DFT study of the reactivity of OH groups in quercetin and taxifolin
antioxidants: The specificity of the 3-OH site. Food Chem 2006, 97,
679−688.
Journal of Medicinal Chemistry Article
DOI: 10.1021/acs.jmedchem.8b01994
J. Med. Chem. 2019, 62, 1657−1668
1667
(33) Anouar, E.; Calliste, C. A.; Kosǐnova,́ P.; Di Meo, F.; Duroux, J.
L.; Champavier, Y.; Marakchi, K.; Trouillas, P. Free radical scavenging
properties of guaiacol oligomers: a combined experimental and
quantum study of the guaiacyl-moiety role. J. Phys. Chem. A 2009,
113, 13881−13891.
(34) Leopoldini, M.; Russo, N.; Toscano, M. The molecular basis of
working mechanism of natural polyphenolic antioxidants. Food Chem
2011, 125, 288−306.
(35) Pastan, I.; Gottesman, M.M.; Ueda, K.; Lovelace, E.; Rutherford,
A. V.; Willingham, M. C. A retrovirus carrying anMDR1 cDNA confers
multidrug resistance and polarized expression of P-glycoprotein in
MDCK cells. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4486−4490.
(36) Pesic, M.; Markovic, J. Z.; Jankovic, D.; Kanazir, S.; Markovic, I.
D.; Rakic, L.; Ruzdijic, S. Induced resistance in the human non small cell
lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs. J.
Chemother. 2006, 18, 66−73.
(37) Mosmann, T. Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assays. J. Immunol.
Methods 1983, 65, 55−63.
(38) Mathew, S.; Abraham, T. E. In vitro antioxidant activity and
scavenging effects of Cinnamomum verum leaf extract assayed by
different methodologies. Food Chem. Toxicol. 2006, 44, 198−206.
(39) Tadolini, B.; Cabrini, L. The influence of pH on OH scavenger
inhibition of damage to deoxyribose by Fenton reaction. Mol. Cell.
Biochem. 1990, 94, 97−104.
Journal of Medicinal Chemistry Article
DOI: 10.1021/acs.jmedchem.8b01994
J. Med. Chem. 2019, 62, 1657−1668
1668
